AstraZeneca PLC has reported a notable performance in the first quarter of 2024, with total revenue reaching $12,679 million, marking a 19% increase at constant exchange rates (CER). The increase was primarily driven by an 18% rise in product sales, bolstered by significant growth in alliance revenue, which surged by 59% at CER. The company […]
In a major strategic move, Spectrum Pharmaceuticals, a prominent US-based biopharma company, has entered into a deal with Acrotech Biopharma, a subsidiary of Aurobindo Pharma USA, to sell seven FDA-approved oncology and hematology drugs for approximately $300 million. The decision is part of Spectrum’s broader strategy to pivot towards innovative cancer therapies, according to the […]
